Treatment of Stage I Non-Hodgkin's Lymphoma
Author Information
Author(s): G.M. Jeffery, G.M. Mead, J.M.A. Whitehouse, R.D.H. Ryall
Primary Institution: CRC Wessex Regional Medical Oncology Unit
Hypothesis
Involved field radiotherapy is effective for managing Stage I nodal intermediate grade non-Hodgkin's lymphoma.
Conclusion
Involved field radiotherapy alone is effective for non-bulky Stage I nodal intermediate grade non-Hodgkin's lymphoma, while bulky disease requires combination chemotherapy.
Supporting Evidence
- 97% of patients with non-bulky disease treated with radiotherapy achieved complete remission.
- 42% of patients relapsed after radiotherapy, but many were salvaged by chemotherapy.
- Overall 5-year survival for the total group was 77%.
Takeaway
Doctors treated 43 patients with a type of cancer called non-Hodgkin's lymphoma. They found that using radiation worked well for smaller tumors, but bigger ones needed chemotherapy.
Methodology
The study reviewed case records of patients diagnosed with intermediate grade non-Hodgkin's lymphoma between 1978 and 1989, focusing on those with Stage I disease confined to lymph nodes.
Limitations
The study did not include patients with mediastinal or extranodal disease, which may limit the generalizability of the findings.
Participant Demographics
{"median_age":61,"age_distribution":{"under_40":7,"40_to_60":15,"over_60":21},"sex_distribution":{"male":26,"female":17}}
Statistical Information
P-Value
0.0125
Statistical Significance
p=0.0125
Want to read the original?
Access the complete publication on the publisher's website